AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Development of Dimethylaminoethyl Methacrylate Based Nanoparticulate Drug Delivery System Using Nanoprecipitation Method and Optimization of Process Parameters Using Plackett-Burman Factorial Design

Moorthi Chidambaram( )Kathiresan Krishnasamy
Department of Pharmacy, Annamalai University, Annamalai Nagar - 608 002, Chidambaram, Tamil Nadu, India
Show Author Information

Abstract

The present study was aimed to develop dimethylaminoethyl methacrylate based nanoparticulate drug delivery system using nanoprecipitation method and optimize the process parameters using PlackettBurman factorial design to yield least average particle size and narrow sized particle distribution without filtration or centrifugation process. Twelve experimental runs involving 11 process parameters at higher and lower levels were generated using Design-Expert. Factorial design result has shown that (a) Except stirring duration all other process parameters significantly influence the average particle size; (B) Except β-cyclodextrin concentration, aqueous phase volume and organic phase volume, all other process parameters significantly influence the polydispersity index; and (C) Except polymer concentration and poloxamer 407 concentration, all other process parameters do not significantly influence the zeta potential. The average particle size, polydispersity index and zeta potential of the prepared dual drug loaded nanoparticles were well within acceptable limits and found to be in the range of 47 to 87 nm, 0.14 to 0.28 and 22 to 39 mV, respectively. Surface morphology examination has shown that the prepared nanoparticles were spherical in shape. The developed dimethylaminoethyl methacrylate based nanoparticulate drug delivery system can be routinely used to fabricate narrow sized polymeric nanoparticles without filtration or centrifugation process.

References

[1]

Moorthi C., Kathiresan K., Nanotoxicology: Toxicity of engineered nanoparticles and approaches to produce safer nanotherapeutics. Int. J. Pharma. Sci. 2012; 2: 117-124.

[2]

Moorthi C., Manavalan R., Kathiresan K., Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J. Pharm. Pharm. Sci. 2011; 14: 67-77.

[3]

Kesisoglou F., Panmai S., Wu Y., Nanosizing - oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliver. Rev. 2007; 59: 631-644.

[4]

Moorthi C., Kathiresan K., Curcumin–Piperine/Curcumin–Quercetin/Curcumin–Silibinin dual drug-loaded nanoparticulate combination therapy: A novel approach to target and treat multidrug-resistant cancers. J. Med. Hypotheses Ideas. 2013; 7: 15-20.

[5]

Gelperina S., Kisich K., Iseman M.D., Heifets L., The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am. J. Resp. Crit. Care. 2005; 172: 1487-1490.

[6]

Moorthi C., Kathiresan K., Application of Plackett-Burman factorial design in the development of curcumin loaded Eudragit E 100 nanoparticles. Nano Biomed. Eng. 2013; 5: 28-33.

[7]

De Jong W.H., Borm P.J., Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 2008; 3: 133-149.

[8]

Moorthi C., Kathiresan K., Fabrication of dual drug loaded polymeric nanosuspension: Incorporating analytical hierarchy process and data envelopment analysis in the selection of a suitable method. Int. J. Pharm. Pharm. Sci. 2013; 5: 499-504.

[9]

Moorthi C., Kathiresan K., A step-by-step optimization process to fabricate narrow sized dual drug loaded polymeric nanoparticles using modified nanoprecipitation technique. Nano Biomed. Eng. 2013; 5(3): 107-115.

[10]

Moorthi C., Kiran K., Manavalan R., Kathiresan K., Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles. Asian Pac. J. Trop. Biomed. 2012; 2(11): 841-848.

[11]

Moorthi C., Senthil kumar C., Mohan S., Kiran K., Kathiresan K., Application of validated RP-HPLC-PDA method for the simultaneous estimation of curcumin and piperine in Eudragit E 100 nanoparticles. Journal of Pharmacy Research. 2013; 7: 224-229.

[12]

Moorthi C., Senthil kumar C., Mohan S., Kathiresan K., SLS/βCD-curcumin nanosuspension: Preparation, characterization and pharmacological evaluation. Journal of Pharmacy Research. 2013; 7: 219-223.

[13]

Moorthi C., Kathiresan K., Reversed phase high performance liquid chromatographic method for simultaneous estimation of curcumin and quercetin in pharmaceutical nanoformulation. Int. J. Pharm. Pharm. Sci. 2013; 5(3): 622-625.

[14]

Moorthi C., Kathiresan K., Simultaneous estimation of curcumin and silibinin using validated RP-HPLCPDA method and its application in pharmaceutical nanoformulation. Int. J. Pharm. Pharm. Sci. 2013; 5(3): 475-478.

[15]

Mora-Huertas C.E., Fessi H., Elaissari A., Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 2010; 385(1-2): 113-142.

[16]

Barichello J.M., Morishita M., Takayama K., Nagai T., Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharm. 1999; 25(4): 471-476.

[17]

Moorthi C., Kathiresan K., Anionic Surfactant Based Topical Curcumin Nanosuspension: Fabrication, Characterization and Evaluation. Nano Biomed. Eng. 2013; 5(2): 86-89.

[18]

Moorthi C., Kathiresan K., Fabrication of highly stable sonication assisted curcumin nanocrystals by nanoprecipitation method. Drug Invention Today. 2013; 5: 66-69.

[19]

Agarwal V., Bajpai M., Stability issues related to nanosuspensions: A review. Pharmaceutical Nanotechnology. 2013; 1: 85-92.

[20]

Bathool A., Vishakante G.D., Khan M.S., Shivakumar H.G., Development and characterization of atorvastatin calcium loaded chitosan nanoparticles for sustain drug delivery. Adv. Mat. Lett. 2012; 3(6): 466-470.

[21]

Yassin A.E.B., Anwer M.K., Mowafy H.A., El-Bagory I.M., Bayomi M.A., Alsarra I.A., Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int. J. Med. Sci. 2010; 7(6): 398-408.

Nano Biomedicine and Engineering
Pages 19-30
Cite this article:
Chidambaram M, Krishnasamy K. Development of Dimethylaminoethyl Methacrylate Based Nanoparticulate Drug Delivery System Using Nanoprecipitation Method and Optimization of Process Parameters Using Plackett-Burman Factorial Design. Nano Biomedicine and Engineering, 2014, 6(1): 19-30. https://doi.org/10.5101/nbe.v6i1.p19-30

296

Views

2

Downloads

0

Crossref

2

Scopus

Altmetrics

Received: 31 October 2013
Accepted: 05 January 2014
Published: 12 March 2014
© 2014 Moorthi Chidambaram and Kathiresan Krishnasamy.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return